Stockreport

TG Therapeutics Shares Rise Almost 30% in 3 Months: Here's Why [Yahoo! Finance]

TG Therapeutics, Inc.  (TGTX) 
Last tg therapeutics, inc. earnings: 11/12 07:34 am Check Earnings Report
US:NASDAQ Investor Relations: ir.tgtherapeutics.com
PDF The company's sole marketed drug Briumvi (ublituximab-xiiy) was approved by the FDA for the treatment of adult patients with relapsing forms of multiple sclerosis (RMS) [Read more]